Ohm Laboratories, Inc. (Ohm), acquired by Ranbaxy in 1995, manufactures prescription and Over-the-Counter (OTC) drugs in solid dose forms (capsules and tablets) and is U.S. Drug Enforcement Agency (DEA) approved to manufacture controlled substances. Our state-of-the-art laboratory, manufacturing and warehousing facilities are capable of handling high-volume products and large batch sizes, while our supply chain efficiency ensures seamless transportation to customer locations. We are a frontrunner in bringing unique product deliveries and complex combinations to the market. We use cutting-edge technology to meet all our customer needs and offer full-service, customized marketing and promotional programs designed to meet the growing needs of retailers, wholesalers and consumers. Mission:?Our Mission: Enriching lives globally, with quality and affordable pharmaceuticals. Our Philosophy: Quality and Patients First
51 to 200
TypeSubsidiary or Business Segment
Revenue$25 to $50 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded1983